Advisory Committee; Cellular, Tissue, and Gene Therapies Advisory Committee; Renewal
Updated under an hour ago ()
The Food and Drug Administration (FDA) is announcing the renewal of the Cellular, Tissue, and Gene Therapies Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Cellular, Tissue, and Gene Therapies Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the October 28, 2028, expiration date.
- Tags
- health IT, Notice, Health and Human Services Department, Food and Drug Administration
- Related exam domains
- CISSP 7: Security Operations
- Source record id
- 2026-20989
- First seen by InfoSec Signals
- 10/14/2026
Source: Federal Register API, Office of the Federal Register, National Archives and Records Administration about this source more from it
Exam domain labels come from a keyword heuristic and are study hints, not an official mapping. The summary is the publisher's own text, shortened; the linked record is authoritative.